Member login 

COELIAC DISEASE AND COVID-19 SURVEY (NZ RESPONSES)

As of May 12th (after 37 days) there had been 420 responses in NZ.

Participants of the survey were predominantly female (86%), median age of 45 years.

The average time since coeliac disease diagnosis was 10.1 years and of those diagnoses, most were done with both blood tests AND biopsy (79%). Most patients state that their coeliac disease is well controlled (74.9%) and only 6.8% have symptoms more than twice a month. Only 3% were on steroids and 4% on immunosuppressant medicines. Participants mostly follow a strict gluten-free diet (GFD) (70%) .

Eighteen patients (4%) have attended the emergency department due to COVID related symptoms. There have been 19 tests for COVID-19 and none tested positive. In the last month,76 (18%) participants had respiratory symptoms, but no patient was hospitalized for a respiratory infection.

58% of patients state that their knowledge on how COVID may affect coeliac disease patients is poor or very poor.

Most participants are not taking extra precautions for COVID-19 as a result of their coeliac disease (61.6%), while 32.2% do, stating they follow social distancing/isolation/PPE use.

Most participants are not aware or are unsure if there is a generally increased risk of infection due to their coeliac disease (75.7%) and 76.2% state the same in terms of their COVID-19 risk.

Patients generally learn about the relationship between COVID-19 and coeliac disease through internet (50.4%) with 62.2% wanting more information.

 

If you have not completed the survey and would like to participate please use the link below:

https://redcapfarncombe.mcmaster.ca/surveys/?s=MY749FDFTL

Request for survey participation from Professor Andrew Day (Chair)

Coeliac NZ Medical Advisory Panel

Our Medical Advisors

Allergy Free and Healthy Living Show 2019
linkedin facebook pinterest youtube rss twitter instagram facebook-blank rss-blank linkedin-blank pinterest youtube twitter instagram